Literature DB >> 28856613

The heart rate response to regadenoson in patients with atrial fibrillation.

Anezi I Uzendu1,2, Ami Iskandrian3, Fadi G Hage4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28856613     DOI： 10.1007/s12350-017-1051-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  19 in total

1.  Heart rate response to regadenoson: Making the case for its value in clinical practice.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-08-27       Impact factor: 5.952

Review 2.  Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification.

Authors:  P J Schwartz; M T La Rovere; E Vanoli
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  Autonomic innervation of the human cardiac conduction system: changes from infancy to senility--an immunohistochemical and histochemical analysis.

Authors:  L T Chow; S S Chow; R H Anderson; J A Gosling
Journal:  Anat Rec       Date:  2001-10-01

4.  Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET.

Authors:  Naveen Bellam; Emir Veledar; Sharmila Dorbala; Marcelo F Di Carli; Sana Shah; Danny Eapen; Arshed Quyyumi; Rob S B Beanlands; Michael E Merhige; Brent A Williams; Benjamin J W Chow; James K Min; Daniel S Berman; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2014-01-31       Impact factor: 5.952

5.  Autonomic nervous system activity as risk predictor in the medical emergency department: a prospective cohort study.

Authors:  Christian Eick; Konstantinos D Rizas; Christine S Meyer-Zürn; Patrick Groga-Bada; Wolfgang Hamm; Florian Kreth; Dietrich Overkamp; Peter Weyrich; Meinrad Gawaz; Axel Bauer
Journal:  Crit Care Med       Date:  2015-05       Impact factor: 7.598

6.  Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging.

Authors:  Shishir Mathur; Anuj R Shah; Alan W Ahlberg; Deborah M Katten; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2010-05-19       Impact factor: 5.952

7.  A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.

Authors:  Fadi G Hage; Phillip Dean; Fahad Iqbal; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-07-22       Impact factor: 5.952

8.  The prognostic value of regadenoson myocardial perfusion imaging.

Authors:  Fadi G Hage; Gopal Ghimire; Davis Lester; Joshua Mckay; Steven Bleich; Stephanie El-Hajj; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2015-02-14       Impact factor: 5.952

9.  Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.

Authors:  Fahad M Iqbal; Wael Al Jaroudi; Kumar Sanam; Aaron Sweeney; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  Am J Cardiol       Date:  2012-10-27       Impact factor: 2.778

10.  Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.

Authors:  Fadi G Hage; Jaekyeong Heo; Billy Franks; Luiz Belardinelli; Brent Blackburn; Whedy Wang; Ami E Iskandrian
Journal:  Am Heart J       Date:  2009-03-06       Impact factor: 4.749
View more
  2 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

2.  Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging.

Authors:  Athanasios Katsikis; Elena Kyrozi; Vasiliki Manira; Athanasios Theodorakos; Julia Malamitsi; Virginia Tsapaki; Ioannis Iakovou; Vasilios Voudris; Genovefa Kolovou; Maria Koutelou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-14       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.